Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States

Abstract

National guidelines endorse adjuvant chemotherapy ± radiotherapy (C ± RT) for early-stage gastric cancer (ESGC). Compliance with these guidelines and the specific impact of adjuvant C ± RT on overall survival (OS) in ESGC have not been extensively explored. The National Cancer Data Base was queried for stage IB-II gastric adenocarcinoma patients undergoing… (More)
DOI: 10.1245/s10434-016-5224-1

Topics

7 Figures and Tables

Cite this paper

@article{Datta2016MultimodalityTI, title={Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States}, author={Jashodeep Datta and Matthew T. McMillan BA and Luis Ruffolo BA and Lea Lowenfeld and Ronac Mamtani MD MSCE and John P. Plastaras and Daniel T. Dempsey MD MBA and Giorgos Constantine Karakousis and Jeffrey A. Drebin and Douglas L. Fraker and Robert E. Roses}, journal={Annals of Surgical Oncology}, year={2016}, volume={23}, pages={2936-2945} }